← Leaderboards
Seung K Kim
Stanford University
$34,748,747
Attributed
$59,425,621
Total exposure
30
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.9M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$85,005,452 · 32
By mechanism
U01$23,803,354 · 5
P30$19,816,005 · 7
R01$19,375,650 · 12
P01$12,275,604 · 5
UC4$5,407,251 · 2
T32$4,327,588 · 1
Top collaborators
- Alvin Carter Powers18 shared
- Patrick Macdonald11 shared
- Roland W Stein9 shared
- Aida Habtezion7 shared
- Walter Gwang-Up Park7 shared
- Mark A Atkinson6 shared
- Rita Bottino6 shared
- Marcela Brissova6 shared
Most similar at Stanford University
Same institution · by research overlap
- Gerald R. Crabtree$18,872,595
- Aida Habtezion$9,853,530
- Walter Gwang-Up Park$7,872,399
- Claire Nicole Bedbrook$367,158
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusIsletPancreasCellsBaseSignal TransductionBeta CellGeneticResearch PersonnelInsulinIslets Of LangerhansMolecularBiologyIslet CellProgramsResourcesGrowthNon-Insulin-Dependent Diabetes MellitusMemberIn VivoTissuesCollaborationsInsulin-Dependent Diabetes MellitusMalignant Neoplasm Of Pancreas
Grant awards (124)
Pancreatic Cancer Development: Genetic and Immune Regulation$2,023,000
P01 · FY2025 · CA · contact PI
Stanford Diabetes Research Center$1,967,401
P30 · FY2025 · DK · contact PI
Mechanisms of islet compensation for β-cell mass deficiency in diabetes$718,912
R01 · FY2025 · DK
Investigating mechanisms underlying diabetes associated with exocrine pancreas diseases$550,481
R01 · FY2025 · DK · contact PI
Administrative Core$370,682
P30 · FY2025 · DK · contact PI
Core C: CODEX Core$340,368
P01 · FY2025 · CA · contact PI
Stanford Islet Research Core$215,005
P30 · FY2025 · DK · contact PI
Administrative and Biostatistics Core$185,376
P01 · FY2025 · CA · contact PI
Stanford Diabetes Research Center$1,967,401
P30 · FY2024 · DK · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,921,851
P01 · FY2024 · CA · contact PI
Human Pancreas Analysis Program-T2D$1,055,999
U01 · FY2024 · DK
Genetic and physiologic regulation of pig islet development and function$596,230
R01 · FY2024 · DK · contact PI
Investigating mechanisms underlying diabetes associated with exocrine pancreas diseases$577,694
R01 · FY2024 · DK · contact PI
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes$484,046
R01 · FY2024 · DK
Administrative Core$370,682
P30 · FY2024 · DK · contact PI
Core C: CODEX Core$323,349
P01 · FY2024 · CA · contact PI
Stanford Islet Research Core$215,005
P30 · FY2024 · DK · contact PI
Administrative and Biostatistics Core$176,106
P01 · FY2024 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,982,541
P01 · FY2023 · CA · contact PI
Stanford Diabetes Research Center$1,967,401
P30 · FY2023 · DK · contact PI
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2023 · DK
Genetic and physiologic regulation of pig islet development and function$635,622
R01 · FY2023 · DK · contact PI
In vivo systems to discover mechanisms regulating human islet alpha cell function$538,870
R01 · FY2023 · DK · contact PI
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes$504,136
R01 · FY2023 · DK
Administrative Core$370,682
P30 · FY2023 · DK · contact PI
Human Pancreas Analysis Program-T2D$350,000
U01 · FY2023 · DK
Core C: CODEX Core$333,560
P01 · FY2023 · CA · contact PI
Stanford Islet Research Core$215,005
P30 · FY2023 · DK · contact PI
Administrative and Biostatistics Core$181,668
P01 · FY2023 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$1,972,084
P01 · FY2022 · CA · contact PI
Stanford Diabetes Research Center$1,967,401
P30 · FY2022 · DK · contact PI
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2022 · DK
Therapeutic targeting of human islets with recombinant regulatory T cells$709,922
U01 · FY2022 · DK · contact PI
Genetic and physiologic regulation of pig islet development and function$649,675
R01 · FY2022 · DK · contact PI
In vivo systems to discover mechanisms regulating human islet alpha cell function$538,911
R01 · FY2022 · DK · contact PI
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes$504,059
R01 · FY2022 · DK
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans$395,040
R01 · FY2022 · DK · contact PI
Administrative Core$370,682
P30 · FY2022 · DK · contact PI
Core C: CODEX Core$333,562
P01 · FY2022 · CA · contact PI
Stanford Islet Research Core$215,005
P30 · FY2022 · DK · contact PI
Administrative and Biostatistics Core$181,669
P01 · FY2022 · CA · contact PI
Pancreatic Cancer Development: Genetic and Immune Regulation$2,129,462
P01 · FY2021 · CA · contact PI
Stanford Diabetes Research Center$1,505,236
P30 · FY2021 · DK · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$722,946
U01 · FY2021 · DK · contact PI
Genetic and physiologic regulation of pig islet development and function$690,488
R01 · FY2021 · DK · contact PI
In vivo systems to discover mechanisms regulating human islet alpha cell function$538,951
R01 · FY2021 · DK · contact PI
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes$524,192
R01 · FY2021 · DK
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U$401,098
R01 · FY2021 · DK · contact PI
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans$395,089
R01 · FY2021 · DK · contact PI
Administrative and Biostatistics Core$191,008
P01 · FY2021 · CA · contact PI
Administrative Core$180,683
P30 · FY2021 · DK · contact PI
Islet Procurement and Research Core$172,768
P30 · FY2021 · DK · contact PI
Stanford Diabetes Research Center$1,521,079
P30 · FY2020 · DK · contact PI
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2020 · DK
Therapeutic targeting of human islets with recombinant regulatory T cells$735,602
U01 · FY2020 · DK · contact PI
In vivo systems to discover mechanisms regulating human islet alpha cell function$567,324
R01 · FY2020 · DK · contact PI
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U$400,545
R01 · FY2020 · DK · contact PI
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans$395,133
R01 · FY2020 · DK · contact PI
Islet Procurement and Research Core$188,610
P30 · FY2020 · DK · contact PI
Administrative Core$180,684
P30 · FY2020 · DK · contact PI
Human Pancreas Analysis Program-T2D$1,899,738
U01 · FY2019 · DK
Stanford Diabetes Research Center$1,535,336
P30 · FY2019 · DK · contact PI
Therapeutic targeting of human islets with recombinant regulatory T cells$762,962
U01 · FY2019 · DK · contact PI
Reconstituting human pancreatic cancer development for translational research$515,614
R01 · FY2019 · CA · contact PI
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U$400,022
R01 · FY2019 · DK · contact PI
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer$397,128
U01 · FY2019 · DK
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans$395,174
R01 · FY2019 · DK · contact PI
Islet Procurement and Research Core$202,868
P30 · FY2019 · DK · contact PI
Enhancing Enrollment for NOD and DETECT studies of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer$192,088
U01 · FY2019 · DK
Administrative Core$180,683
P30 · FY2019 · DK · contact PI
Stanford Diabetes Research Center$1,551,177
P30 · FY2018 · DK · contact PI
Reconstituting human pancreatic cancer development for translational research$515,614
R01 · FY2018 · CA · contact PI
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer$402,146
U01 · FY2018 · DK
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U$399,537
R01 · FY2018 · DK · contact PI
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humans$395,208
R01 · FY2018 · DK · contact PI
Administrative Supplement for Stanford Unit: CPDPC$272,546
U01 · FY2018 · DK
Islet Procurement and Research Core$218,709
P30 · FY2018 · DK · contact PI
Administrative Core$180,683
P30 · FY2018 · DK · contact PI
Stanford Diabetes Research Center$1,568,461
P30 · FY2017 · DK · contact PI
CAR T cell targeting of human islets$1,446,086
UC4 · FY2017 · DK · contact PI
Reconstituting human pancreatic cancer development for translational research$515,614
R01 · FY2017 · CA · contact PI
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer$404,605
U01 · FY2017 · DK
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin U$399,082
R01 · FY2017 · DK · contact PI
NFAT control of pancreatic islet beta-cell functional maturation$346,665
R01 · FY2017 · DK · contact PI
Islet Procurement and Research Core$235,993
P30 · FY2017 · DK · contact PI
Administrative Core$180,683
P30 · FY2017 · DK · contact PI
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer$412,196
U01 · FY2016 · DK
NFAT control of pancreatic islet beta-cell functional maturation$346,710
R01 · FY2016 · DK · contact PI
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer$394,220
U01 · FY2015 · DK
NFAT control of pancreatic islet beta-cell functional maturation$361,226
R01 · FY2015 · DK · contact PI
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$163,876
UC4 · FY2015 · DK
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$2,468,076
UC4 · FY2014 · DK
Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas$1,329,213
UC4 · FY2014 · DK
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate$100,000
U01 · FY2014 · DK · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$99,995
U01 · FY2014 · DK
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,014,083
U01 · FY2013 · DK
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate$883,290
U01 · FY2013 · DK · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,064,200
U01 · FY2012 · DK
Medical Scientist Training Program$1,142,055
T32 · FY2012 · GM · contact PI
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate$943,959
U01 · FY2012 · DK · contact PI
Medical Scientist Training Program$49,655
T32 · FY2012 · GM · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,089,419
U01 · FY2011 · DK
Medical Scientist Training Program$996,411
T32 · FY2011 · GM · contact PI
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate$753,446
U01 · FY2011 · DK · contact PI
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and Regeneration$2,089,419
U01 · FY2010 · DK
Medical Scientist Training Program$1,072,157
T32 · FY2010 · GM · contact PI
Epigenetic and Genetic Control of Human and Murine Beta Cell Development and Fate$753,445
U01 · FY2010 · DK · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$301,272
R01 · FY2010 · DK · contact PI
Men1 Control of Endocrine Cell Growth and Differentiation$281,495
R01 · FY2010 · DK · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$86,095
R01 · FY2010 · DK · contact PI
Medical Scientist Training Program$1,018,796
T32 · FY2009 · GM · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$304,315
R01 · FY2009 · DK · contact PI
Men1 Control of Endocrine Cell Growth and Differentiation$283,909
R01 · FY2009 · DK · contact PI
Medical Scientist Training Program$48,514
T32 · FY2009 · GM · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$304,315
R01 · FY2008 · DK · contact PI
Men1 Control of Endocrine Cell Growth and Differentiation$283,494
R01 · FY2008 · DK · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$310,526
R01 · FY2007 · DK · contact PI
Men1 Control of Endocrine Cell Growth and Differentiation$288,873
R01 · FY2007 · DK · contact PI
Regulation of Facultative Islet Growth and Development by Calcineurin and NFAT$319,800
R01 · FY2006 · DK · contact PI
Men1 Control of Endocrine Cell Growth & Differentiation$297,098
R01 · FY2006 · DK · contact PI
Control of Pancreas Growth/Development$279,649
R01 · FY2004 · DK
Control of Pancreas Growth/Development$279,461
R01 · FY2003 · DK
Control of Pancreas Growth/Development$279,280
R01 · FY2002 · DK
Control of Pancreas Growth/Development$279,106
R01 · FY2001 · DK